Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4K9E

Crystal structure of KIT D4D5 fragment in complex with anti-Kit antibodies Fab79D

4K9E の概要
エントリーDOI10.2210/pdb4k9e/pdb
関連するPDBエントリー4K94
分子名称light chain, heavy chain, Mast/stem cell growth factor receptor Kit, ... (5 entities in total)
機能のキーワードreceptor tyrosine kinase (rtk), igg, fab, immune system
由来する生物種Mus musculus
詳細
タンパク質・核酸の鎖数3
化学式量合計72746.16
構造登録者
Resheynyak, A.V.,Boggon, T.J.,Lax, I.,Schlessinger, J. (登録日: 2013-04-19, 公開日: 2013-10-16, 最終更新日: 2024-11-27)
主引用文献Reshetnyak, A.V.,Nelson, B.,Shi, X.,Boggon, T.J.,Pavlenco, A.,Mandel-Bausch, E.M.,Tome, F.,Suzuki, Y.,Sidhu, S.S.,Lax, I.,Schlessinger, J.
Structural basis for KIT receptor tyrosine kinase inhibition by antibodies targeting the D4 membrane-proximal region.
Proc.Natl.Acad.Sci.USA, 110:17832-17837, 2013
Cited by
PubMed Abstract: Somatic oncogenic mutations in the receptor tyrosine kinase KIT function as major drivers of gastrointestinal stromal tumors and a subset of acute myeloid leukemia, melanoma, and other cancers. Although treatment of these cancers with tyrosine kinase inhibitors shows dramatic responses and durable disease control, drug resistance followed by clinical progression of disease eventually occurs in virtually all patients. In this report, we describe inhibitory KIT antibodies that bind to the membrane-proximal Ig-like D4 of KIT with significant overlap with an epitope in D4 that mediates homotypic interactions essential for KIT activation. Crystal structures of the anti-KIT antibody in complex with KIT D4 and D5 allowed design of affinity-matured libraries that were used to isolate variants with increased affinity and efficacy. Isolated antibodies showed KIT inhibition together with suppression of cell proliferation driven by ligand-stimulated WT or constitutively activated oncogenic KIT mutant. These antibodies represent a unique therapeutic approach and a step toward the development of "naked" or toxin-conjugated KIT antibodies for the treatment of KIT-driven cancers.
PubMed: 24127596
DOI: 10.1073/pnas.1317118110
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.7 Å)
構造検証レポート
Validation report summary of 4k9e
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon